CRON Q1 2023 Earnings — Cronos Group Inc. Revenue & Financial Results | Market Cap Arena

CRONCronos Group Inc.

$983M

Q1 2023 Earnings

Healthcare Drug Manufacturers - Specialty & Generic

Income Statement

Revenue

$19M-31.3% YoY

Gross Profit

$3M15.0% margin

Operating Income

-$21M-106.5% margin

Net Income

-$19M-98.3% margin

EPS (Diluted)

$-0.05

QoQ Revenue Growth

-14.8%

Cash Flow

Operating Cash Flow

-$48M

Free Cash Flow

-$48M

Stock-Based Comp.

$3M

Balance Sheet

Total Assets

$1.2B

Total Liabilities

$33M

Stockholders' Equity

$1.1B

Cash & Equivalents

$414M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$19M	$28M	-31.3%
Gross Profit	$3M	$8M	-65.1%
Operating Income	-$21M	-$40M	+47.7%
Net Income	-$19M	-$41M	+53.0%

Revenue Segments

Cannabis Flower

$13M65%

Cannabis Extracts

$7M35%

Product and Service, Other

$66,0000%

Geographic Segments

CANADA

$14M72%

ISRAEL

$5M25%

UNITED STATES

$649,0003%